InnovAge Holding Corp. Operating Income
InnovAge Holding Corp. (INNV) reported Operating Income of $2.62 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-09-09
- InnovAge Holding Corp. operating income (loss) for the quarter ending 2026-06-30 was $10.15M.
- InnovAge Holding Corp. operating income (loss) for the quarter ending 2026-03-31 was -$29.08M.
- InnovAge Holding Corp. operating income (loss) for the quarter ending 2025-12-31 was $13.26M.
- InnovAge Holding Corp. operating income (loss) for the quarter ending 2025-09-30 was $8.29M.
- InnovAge Holding Corp. operating income (loss) for fiscal 2026 was $2.62M.
- InnovAge Holding Corp. operating income (loss) for fiscal 2025 was -$29.76M.
- InnovAge Holding Corp. operating income (loss) for fiscal 2024 was -$23.18M.
- InnovAge Holding Corp. operating income (loss) for fiscal 2023 was -$49.40M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$18.93M derived: sum of 2 quarters · filed 2026-09-09 | -$5.67M derived: sum of 3 quarters · filed 2026-09-09 | $2.62M 10-K · filed 2026-09-09 |
| 2026-03-31 | -$29.08M 10-Q · filed 2026-05-08 | -$15.82M derived: sum of 2 quarters · filed 2026-05-08 | -$7.53M 10-Q · filed 2026-05-08 | -$9.68M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $13.26M 10-Q · filed 2026-02-03 | $21.55M 10-Q · filed 2026-02-03 | $19.40M derived: sum of 3 quarters · filed 2026-09-09 | $9.24M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $8.29M 10-Q · filed 2025-11-04 | $6.14M derived: sum of 2 quarters · filed 2026-09-09 | -$4.02M derived: sum of 3 quarters · filed 2026-09-09 | -$16.57M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$12.31M derived: sum of 2 quarters · filed 2026-09-09 | -$24.86M derived: sum of 3 quarters · filed 2026-09-09 | -$29.76M 10-K · filed 2026-09-09 |
| 2025-03-31 | -$10.16M 10-Q · filed 2026-05-08 | -$22.71M derived: sum of 2 quarters · filed 2026-05-08 | -$27.61M 10-Q · filed 2026-05-08 | -$32.49M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$12.56M 10-Q · filed 2026-02-03 | -$17.45M 10-Q · filed 2026-02-03 | -$22.34M derived: sum of 3 quarters · filed 2026-02-03 | -$28.13M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$4.90M 10-Q · filed 2025-11-04 | -$9.78M derived: sum of 2 quarters · filed 2025-11-04 | -$15.57M derived: sum of 3 quarters · filed 2025-11-04 | -$17.36M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | -$10.68M derived: sum of 2 quarters · filed 2025-09-09 | -$12.46M derived: sum of 3 quarters · filed 2025-09-09 | -$23.18M 10-K · filed 2025-09-09 |
| 2024-03-31 | -$5.79M 10-Q · filed 2025-05-06 | -$7.58M derived: sum of 2 quarters · filed 2025-05-06 | -$18.30M 10-Q · filed 2025-05-06 | -$29.24M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$1.78M 10-Q · filed 2025-02-04 | -$12.50M 10-Q · filed 2025-02-04 | -$23.45M derived: sum of 3 quarters · filed 2025-02-04 | -$31.61M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | -$10.72M 10-Q · filed 2024-11-05 | -$21.66M derived: sum of 2 quarters · filed 2024-11-05 | -$29.83M derived: sum of 3 quarters · filed 2024-11-05 | -$43.51M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$10.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | -$19.11M derived: sum of 2 quarters · filed 2024-09-10 | -$32.79M derived: sum of 3 quarters · filed 2024-09-10 | -$49.40M 10-K · filed 2024-09-10 |
| 2023-03-31 | -$8.17M 10-Q · filed 2024-05-07 | -$21.85M derived: sum of 2 quarters · filed 2024-05-07 | -$38.45M 10-Q · filed 2024-05-07 | -$50.80M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$13.68M 10-Q · filed 2024-02-06 | -$30.28M 10-Q · filed 2024-02-06 | -$42.63M derived: sum of 3 quarters · filed 2024-02-06 | -$49.30M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | -$16.60M 10-Q · filed 2023-11-07 | -$28.95M derived: sum of 2 quarters · filed 2023-11-07 | -$35.62M derived: sum of 3 quarters · filed 2023-11-07 | -$32.67M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$12.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | -$19.02M derived: sum of 2 quarters · filed 2023-09-12 | -$16.07M derived: sum of 3 quarters · filed 2023-09-12 | -$4.41M 10-K · filed 2023-09-12 |
| 2022-03-31 | -$6.67M 10-Q · filed 2023-05-09 | -$3.72M derived: sum of 2 quarters · filed 2023-05-09 | $7.94M 10-Q · filed 2023-05-09 | $18.61M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.95M 10-Q · filed 2023-02-07 | $14.61M 10-Q · filed 2023-02-07 | $25.28M derived: sum of 3 quarters · filed 2023-02-07 | $19.91M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $11.66M 10-Q · filed 2022-11-08 | $22.33M derived: sum of 2 quarters · filed 2022-11-08 | $16.96M derived: sum of 3 quarters · filed 2022-11-08 | $37.50M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $10.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $5.30M derived: sum of 2 quarters · filed 2022-09-13 | $25.84M derived: sum of 3 quarters · filed 2022-09-13 | -$12.34M 10-K · filed 2022-09-13 |
| 2021-03-31 | -$5.37M 10-Q · filed 2022-05-10 | $15.18M derived: sum of 2 quarters · filed 2022-05-10 | -$23.00M 10-Q · filed 2022-05-10 | -$2.83M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $20.54M 10-Q · filed 2022-02-09 | -$17.64M 10-Q · filed 2022-02-09 | $2.53M derived: sum of 3 quarters · filed 2022-02-09 | $15.51M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | -$38.18M 10-Q · filed 2021-11-09 | -$18.01M derived: sum of 2 quarters · filed 2021-11-09 | -$5.04M derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $20.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $33.14M derived: sum of 2 quarters · filed 2021-09-23 | $50.93M 10-K · filed 2021-09-23 | |
| 2020-03-31 | $12.97M 10-Q · filed 2021-05-11 | $30.76M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |